Biopharma has won a government tender for the delivery of Biovenum Mono to the Republic of Belarus.
Biopharma has won a government tender for the delivery of Biovenum Mono to the Republic of Belarus. The immunoglobulin for use in pediatric practice will be delivered quarterly during the year 2018. Biovenum Mono was registered in Belarus in 2009 and is delivered from 2012 on a regular basis. The antibody meets European Pharmacopoeia’s standards.